Key Insights

Highlights

Success Rate

96% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

2.2%

2 terminated out of 89 trials

Success Rate

96.0%

+9.5% vs benchmark

Late-Stage Pipeline

21%

19 trials in Phase 3/4

Results Transparency

21%

10 of 48 completed with results

Key Signals

10 with results96% success

Data Visualizations

Phase Distribution

65Total
Not Applicable (37)
P 1 (2)
P 2 (7)
P 3 (7)
P 4 (12)

Trial Status

Completed48
Unknown13
Recruiting13
Not Yet Recruiting7
Active Not Recruiting4
Terminated2

Trial Success Rate

96.0%

Benchmark: 86.5%

Based on 48 completed trials

Clinical Trials (89)

Showing 20 of 20 trials
NCT06645106Not ApplicableRecruitingPrimary

Offering Routine and Rapid Point of Care (POC) Syphilis Testing in Pregnant Patients Presenting to the Emergency Department

NCT06428643Not ApplicableRecruiting

A Seek, Test, and Treat Intervention to Reduce Chlamydia Trachomatis Disparities

NCT06927843Active Not RecruitingPrimary

Investigational Study to Evaluate the DPP® Syphilis Screen & Confirm Antibody Point-of-care Test (POCT) to Diagnose Infectious Syphilis

NCT04958122Phase 3RecruitingPrimary

Cefixime Clinical Trial

NCT06766331Not ApplicableNot Yet Recruiting

Integrated Care Versus Usual Care for Opioid Use Disorder and Infectious Diseases in Veterans

NCT04793750Not ApplicableCompleted

Ending the HIV Epidemic Through Point-of-Care Technologies (EHPOC)

NCT07516912Not Yet Recruiting

Evaluation of Free STI Testing Pilot Projects in Lucerne and Zurich, Switzerland

NCT07500415Not ApplicableRecruiting

Doxi-Rio: Study on the Use of Doxycycline to Prevent Sexually Transmitted Infections in Rio de Janeiro

NCT07498153Not ApplicableCompletedPrimary

Spotting Syphilis: A Dual Point-of-Care Syphilis Screening Initiative in a Low-Resource Healthcare Setting

NCT05548426Phase 2Active Not RecruitingPrimary

Linezolid for Syphilis Pilot Study

NCT06187064Not ApplicableCompleted

Combination Primary Care and Prevention Services for Women Who Inject Drugs and Exchange Sex in Seattle, Washington

NCT07388979Not Yet Recruiting

MAGIA H3S Point of Care Test Performance for HIV, HBV, HCV, and Syphilis Screening in Pregnant Women in DR Congo

NCT07170748Recruiting

Clinical Performance Evaluation of MagIA IVD-MD Multiplex Testing (HIV/HBV/HCV/Syphilis)

NCT05831098Not ApplicableCompleted

Evaluation of the Sensitivity, Specificity, and Utility of the Reveal® TP (Syphilis) Antibody POCT

NCT07300254RecruitingPrimary

Treponemal Shedding, Load, and Viability, in Women and Men-who-have-sex-with-women-only With Early Infectious Syphilis: Implications for Transmission

NCT07317687Not Yet Recruiting

Rapid HIV, Hep C, and Syphilis Screening in a Rural Street Medicine Clinic

NCT06738407Phase 4Not Yet Recruiting

Doxycycline Prophylaxis for Prevention of Sexually Transmitted Infections

NCT04838717Phase 3CompletedPrimary

Clinical Trial of Doxycycline VS BPG for Early Syphilis (SY-DOXY)

NCT06586905Not ApplicableRecruitingPrimary

A Cross-sectional Investigational Study to Evaluate the Sensitivity, Specificity, and Utility of the MedMira Inc. Multiplo® Complete Syphilis (TP/nTP) Antibody Test (POCT) to Diagnose Infectious Syphilis in Participants Attending the Sexual Health Clinic in Ottawa, Ontario.

NCT06082453Not ApplicableRecruitingPrimary

Modernizing Perinatal Syphilis Testing

Scroll to load more

Research Network

Activity Timeline